Kestra Advisory Services’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Kestra Advisory Services's UTHR Position: Q3 2026 in Review
Kestra Advisory Services increased its United Therapeutics (UTHR) stake by 10% in Q3 2026, buying an estimated $72.9K and bringing the position to 1,496 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.
Kestra Advisory Services first reported a position in UTHR in Q2 2022 and has held it in 13 quarters since. 276 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Kestra Advisory Services held 1,496 shares of United Therapeutics worth $811K as of Q3 2026.
- Kestra Advisory Services bought 141 United Therapeutics shares in Q3 2026, an estimated $72.9K.
- United Therapeutics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2109 holding.
- Kestra Advisory Services first reported a position in United Therapeutics in Q2 2022 and has held it in 13 quarters since.
- 276 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.